Covalon Technologies Ltd
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally. The company's platform technologies comprises collagen matrix platform that is used to manufacture a family of products to… Read more
Covalon Technologies Ltd (CVALF) - Total Liabilities
Latest total liabilities as of September 2025: $5.40 Million USD
Based on the latest financial reports, Covalon Technologies Ltd (CVALF) has total liabilities worth $5.40 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Covalon Technologies Ltd - Total Liabilities Trend (2007–2025)
This chart illustrates how Covalon Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Covalon Technologies Ltd Competitors by Total Liabilities
The table below lists competitors of Covalon Technologies Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Purit Co. Ltd.
KQ:445180
|
Korea | ₩14.10 Billion |
|
Evertex Fabrinology Ltd
TW:1470
|
Taiwan | NT$160.17 Million |
|
Hotel Property Investments Ltd
AU:HPI
|
Australia | AU$506.34 Million |
|
Busan Ind
KO:011390
|
Korea | ₩157.47 Billion |
|
Fountain Set (Holdings) Limited
F:FOV
|
Germany | €1.15 Billion |
|
Huvis Corporation
KO:079980
|
Korea | ₩501.60 Billion |
|
Golden State Bancorp
OTCQX:GSBX
|
USA | $849.06 Million |
|
RFTech Co. Ltd
KQ:061040
|
Korea | ₩230.66 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Covalon Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Covalon Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Covalon Technologies Ltd (2007–2025)
The table below shows the annual total liabilities of Covalon Technologies Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $5.40 Million | +25.45% |
| 2024-09-30 | $4.30 Million | -29.57% |
| 2023-09-30 | $6.11 Million | -0.68% |
| 2022-09-30 | $6.15 Million | -14.68% |
| 2021-09-30 | $7.21 Million | -71.83% |
| 2020-09-30 | $25.59 Million | +3.70% |
| 2019-09-30 | $24.68 Million | +274.85% |
| 2018-09-30 | $6.58 Million | +120.47% |
| 2017-09-30 | $2.99 Million | +11.38% |
| 2016-09-30 | $2.68 Million | -5.76% |
| 2015-09-30 | $2.84 Million | +30.94% |
| 2014-09-30 | $2.17 Million | -17.77% |
| 2013-09-30 | $2.64 Million | -4.90% |
| 2012-09-30 | $2.78 Million | +26.46% |
| 2011-09-30 | $2.20 Million | -17.79% |
| 2010-09-30 | $2.67 Million | +48.35% |
| 2009-09-30 | $1.80 Million | -15.79% |
| 2008-09-30 | $2.14 Million | -20.00% |
| 2007-09-30 | $2.67 Million | -- |